Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic is not ...

New data shows that more patients with type 2 diabetes achieved an average blood sugar level below 7% after using Novo Nordisk’s Victoza (liraglutide) for the first time, at any given time point ...

Victoza is another injectable GLP-1 medication that is similar to Ozempic. It’s approved to lower blood sugar levels in adults with type 2 diabetes. However, unlike Ozempic, Victoza is injected ...

Liraglutide is on the market as Victoza for diabetes and Saxenda for obesity. It has been largely superseded, however, by Novo Nordisk's semaglutide-based therapies, Ozempic for diabetes and ...

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Use of other weight loss medications, such as phentermine and liraglutide, declined. Among people with type 2 diabetes, 13% started GLP-1RA-based medications in January 2021. That rate rose to 35% ...

The approval of tirzepatide for type 2 diabetes and obesity management has ... phentermine, 3.0-mg liraglutide, 2.4-mg semaglutide, naltrexone–bupropion, orlistat, and phentermine–topiramate.